Vir Biotechnology Inc
NASDAQ:VIR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vir Biotechnology Inc
NASDAQ:VIR
|
US |
|
Z
|
ZincX Resources Corp
XMUN:M9R
|
CA |
|
C
|
China High Speed Transmission Equipment Group Co Ltd
XMUN:BGR
|
KY |
|
Erie Indemnity Co
F:EI2
|
US |
|
E
|
Energy Absolute PCL
SET:EA
|
TH |
Intrinsic Value
Is VIR undervalued or overvalued?
See the intrinsic value estimate for Vir Biotechnology Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
VIR looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with VIR’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Vir Biotechnology Does
Vir Biotechnology is a drug developer focused on infectious diseases. It works on antibody-based medicines and other immune-driven treatments that are designed to help the body fight viral infections, especially diseases where standard antiviral drugs are limited or not enough.
- Headquarters
- United States of America US
- Employees
- 367
- IPO date
- Oct 11, 2019
Revenue & Expenses Breakdown
Vir Biotechnology Inc
Earnings Waterfall
Vir Biotechnology Inc
The intrinsic value for Vir Biotechnology Inc (VIR) under the Base Case is hidden USD.
Compared with the current market price of 10.52 USD, the stock appears hidden.